Squamous atypia in the atrophic cervical vaginal smear
نویسندگان
چکیده
منابع مشابه
Squamous metaplasia without atypia.
An 89-year-old man presented with a 1-month history of anemia. The results of a physical examination were normal. Diagnostic gastrointestinal endoscopy showed advanced atrophic gastritis, multiple ulcer scars, and a whitish, slightly depressed lesion 15mm in size in the lesser curvature of the antrum (●" Fig.1). Squamous metaplasia without atypia was diagnosed based on examination of the specim...
متن کاملThe cost-effectiveness of treating women with a cervical vaginal smear diagnosis of atypical squamous cells of undetermined significance.
OBJECTIVE The purpose was to determine the optimal treatment protocol for women with a cervical vaginal diagnosis of atypical squamous cells of undetermined significance. STUDY DESIGN By means of decision analysis, 8 strategies were compared in terms of cost, life expectancy, cost-effectiveness, and the number of cancers and complications from treatment. Data were obtained from the medical li...
متن کاملCervical Screening (Cervical Smear Test)
Cervical cancer is the third or fourth most common female malignancy worldwide, causing an approximate 529,828 new cases each year. [1] It occurs much more frequently in developing countries. In the UK it is now the 17th most common female cancer, and accounts for 1% of female deaths from cancer. [2] Age-standardised mortality rate for the UK was 2.2 per 100,000 in 2012 (2.1 in England and Wale...
متن کاملCervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion?
Recent studies have described premalignant changes in the endocervical epithelium, but morphological criteria for the diagnosis of cervical glandular atypia of lesser severity than adenocarcinoma in situ have not been established. Adenocarcinoma in situ is often associated with cervical intraepithelial neoplasia (CIN). The endocervical mucosa in 105 cases of CIN grade III was evaluated and comp...
متن کاملCervical Screening (Cervical Smear Test)
Worldwide cervical carcinoma is the second most common female malignancy, causing approximately 500,000 new cases each year. [2] The age-standardised (European) annual incidence rate of cervical cancer is 13.2 per 100,000 females. [2] Age-standardised mortality rate for the UK was 2.9 per 100,000 in 2008. [3] 85-90% are squamous cell cancers and approximately 15% are adenocarcinomas, which are ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1998
ISSN: 0008-543X,1097-0142
DOI: 10.1002/(sici)1097-0142(19980825)84:4<218::aid-cncr6>3.0.co;2-i